×
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
S&P 500   3,845.08
DOW   31,037.68
QQQ   288.80
NASDAQ:KRTX

Karuna Therapeutics Insider Trading & Ownership

$130.85
-1.15 (-0.87%)
(As of 07/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$126.98
$134.00
50-Day Range
$93.97
$132.00
52-Week Range
$92.26
$161.98
Volume
443,953 shs
Average Volume
337,602 shs
Market Capitalization
$3.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$177.70

Karuna Therapeutics (NASDAQ:KRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.20%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$6.01 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$11.82 M

KRTX Insider Buying and Selling by Quarter

Get KRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karuna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Karuna Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/29/2022James HealyDirectorBuy47,777$123.04$5,878,482.082,000,218  
6/9/2022Stephen K BrannanInsiderSell5,000$110.90$554,500.0015,000  
5/27/2022Laurie J. OlsonDirectorSell1,000$110.00$110,000.00  
5/9/2022Stephen K BrannanInsiderSell5,000$104.10$520,500.0015,000  
4/21/2022Troy A IgnelziCFOSell40$134.46$5,378.4024,970  
4/19/2022Troy A IgnelziCFOSell3,500$130.81$457,835.0024,970  
4/1/2022James HealyDirectorBuy47$129.38$6,080.86683  
4/1/2022Stephen K BrannanInsiderSell7,728$128.45$992,661.6015,000  
3/1/2022Stephen K BrannanInsiderSell7,728$107.38$829,832.64  
2/15/2022Laurie J OlsonDirectorSell1,000$110.00$110,000.00  
2/15/2022Troy A IgnelziCFOSell1,500$111.14$166,710.00  
2/1/2022Atul PandeDirectorSell2,500$110.80$277,000.00  
2/1/2022Stephen K BrannanInsiderSell7,728$110.05$850,466.40  
1/3/2022Atul PandeDirectorSell2,500$130.44$326,100.00  
1/3/2022Stephen K BrannanInsiderSell7,728$130.79$1,010,745.12  
12/1/2021Atul PandeDirectorSell2,500$127.73$319,325.00  
12/1/2021Stephen K BrannanInsiderSell7,728$127.57$985,860.96  
11/15/2021Laurie J OlsonDirectorSell1,000$138.24$138,240.00  
11/8/2021Troy A IgnelziCFOSell13,500$152.32$2,056,320.00  
10/1/2021Atul PandeDirectorSell2,500$120.72$301,800.00  
9/1/2021Andrew Craig MillerCOOSell5,500$118.48$651,640.0050,910  
9/1/2021Atul PandeDirectorSell2,500$117.82$294,550.002,500  
8/17/2021Steven M PaulCEOBuy1,183$105.63$124,960.29  
8/16/2021Andrew Craig MillerCOOSell5,500$103.92$571,560.00  
8/2/2021Atul PandeDirectorSell2,500$114.17$285,425.00  
7/2/2021James HealyDirectorBuy636$117.80$74,920.80  
6/16/2021Troy A IgnelziCFOSell2,600$129.31$336,206.0015,248  
6/14/2021Andrew Craig MillerCOOSell8,334$131.44$1,095,420.9658,833  
6/14/2021Troy A IgnelziCFOSell900$132.52$119,268.0015,248  
6/11/2021Andrew Craig MillerCOOSell8,333$129.33$1,077,706.8958,833  
6/7/2021Laurie J OlsonDirectorSell4,000$112.93$451,720.004,000  
6/1/2021Atul PandeDirectorSell2,500$111.44$278,600.002,500  
5/12/2021Troy A IgnelziCFOSell200$120.00$24,000.0020,000  
5/10/2021Andrew Craig MillerCOOSell5,000$110.43$552,150.0050,500  
5/10/2021Troy A IgnelziCFOSell7,000$110.07$770,490.0020,000  
5/3/2021Atul PandeDirectorSell2,500$110.61$276,525.002,500  
4/12/2021Andrew Craig MillerCOOSell5,000$114.22$571,100.0050,500  
4/1/2021Atul PandeDirectorSell2,500$120.01$300,025.002,500  
3/10/2021Andrew Craig MillerCOOSell5,000$118.48$592,400.0050,500  
2/9/2021Puretech Health LlcMajor ShareholderSell1,000,000$118.00$118,000,000.002,406,564  
2/1/2021Atul PandeDirectorSell2,500$100.00$250,000.002,500  
1/11/2021Andrew Craig MillerCOOSell5,000$105.11$525,550.0049,072  
1/8/2021Troy A IgnelziCFOSell8,000$104.49$835,920.0021,000  
12/14/2020Atul PandeDirectorSell5,714$92.64$529,344.965,714  
12/10/2020Andrew Craig MillerCOOSell5,000$94.82$474,100.0045,500  
11/12/2020Andrew Craig MillerCOOSell30,000$101.69$3,050,700.00
11/12/2020Atul PandeDirectorSell5,000$96.84$484,200.00
11/9/2020Troy A IgnelziCFOSell9,318$105.48$982,862.645,564  
11/6/2020Troy A IgnelziCFOSell564$108.15$60,996.605,564  
11/3/2020Atul PandeDirectorSell5,000$85.00$425,000.005,000  
10/12/2020Andrew Craig MillerCOOSell5,000$78.67$393,350.0038,000  
9/16/2020Atul PandeDirectorSell5,000$85.00$425,000.005,000  
9/10/2020Andrew Craig MillerCOOSell5,000$75.52$377,600.0038,000  
9/8/2020James HealyDirectorBuy504$73.00$36,792.00  
9/8/2020Troy A IgnelziCFOSell2,000$73.30$146,600.007,000  
9/4/2020Heather PrestonDirectorBuy350$72.36$25,326.005,800  
8/26/2020Puretech Health LlcMajor ShareholderSell1,333,333$76.21$101,613,307.933,406,564  
7/13/2020Atul PandeDirectorSell5,000$95.43$477,150.005,000  
7/8/2020Troy A IgnelziCFOSell8,000$98.74$789,920.006,000  
7/1/2020Stephen K BrannanInsiderSell7,728$108.53$838,719.8415,000  
6/29/2020Steven M PaulCEOSell292,207$103.50$30,243,424.50  
6/16/2020Andrew Craig MillerCOOSell25,000$94.41$2,360,250.0033,000  
6/15/2020Troy A IgnelziCFOSell6,000$89.75$538,500.002,000  
6/12/2020Andrew Craig MillerCOOSell8,333$93.28$777,302.2433,000  
6/12/2020Edmund HarriganDirectorSell30,000$91.79$2,753,700.0075,163  
6/1/2020Andrew Craig MillerCOOSell25,000$90.64$2,266,000.0025,000  
6/1/2020Stephen K BrannanInsiderSell7,728$90.64$700,465.9212,500  
5/22/2020Puretech Health LlcMajor ShareholderSell555,500$81.03$45,012,165.004,745,397  
5/8/2020Troy A IgnelziCFOSell7,500$83.38$625,350.007,500  
5/1/2020Andrew Craig MillerCOOSell25,000$76.98$1,924,500.0025,000  
5/1/2020Stephen K BrannanInsiderSell7,728$79.38$613,448.6410,000  
4/1/2020Andrew Craig MillerCOOSell25,000$64.37$1,609,250.0010,654  
4/1/2020Stephen K BrannanInsiderSell7,728$67.36$520,558.087,500  
3/12/2020Heather PrestonDirectorBuy2,050$71.71$147,005.503,400  
3/10/2020Heather PrestonDirectorBuy1,000$80.00$80,000.003,400  
1/22/2020Puretech Health LlcMajor ShareholderSell2,100,000$95.67$200,907,000.005,295,397  
1/9/2020Heather PrestonDirectorBuy788$70.50$55,554.002,400  
1/3/2020Heather PrestonDirectorBuy1,427$69.80$99,604.60474  
11/25/2019James HealyDirectorBuy156,250$96.00$15,000,000.00  
7/2/2019Arch Venture Partners Ix, LlcMajor ShareholderBuy200,000$16.00$3,200,000.00  
7/2/2019James HealyDirectorBuy700,000$16.00$11,200,000.00  
6/28/2019Steven M PaulCEOBuy10,000$23.04$230,400.00  
(Data available from 1/1/2013 forward)












Karuna Therapeutics Insider Trading - Frequently Asked Questions

Who is on Karuna Therapeutics's Insider Roster?

The list of insiders at Karuna Therapeutics includes Andrew Craig Miller, Atul Pande, Edmund Harrigan, Heather Preston, James Healy, Laurie J Olson, Puretech Health Llc, Stephen K Brannan, Steven M Paul, and Troy A Ignelzi. Learn more on insiders at KRTX.

What percentage of Karuna Therapeutics stock is owned by insiders?

16.20% of Karuna Therapeutics stock is owned by insiders. Learn more on KRTX's insider holdings.

Which Karuna Therapeutics insiders have been buying company stock?

The following insiders have purchased Karuna Therapeutics stock in the last 24 months: Heather Preston ($25,326.00), James Healy ($5,996,275.74), and Steven M Paul ($124,960.29).

How much insider buying is happening at Karuna Therapeutics?

Insiders have purchased a total of 50,497 Karuna Therapeutics shares in the last 24 months for a total of $6,146,562.03 bought.

Which Karuna Therapeutics insiders have been selling company stock?

The following insiders have sold Karuna Therapeutics stock in the last 24 months: Andrew Craig Miller ($9,933,277.85), Atul Pande ($5,250,044.96), Laurie J Olson ($699,960.00), Puretech Health Llc ($219,613,307.93), Stephen K Brannan ($5,744,566.72), and Troy A Ignelzi ($6,752,506.64).

How much insider selling is happening at Karuna Therapeutics?

Insiders have sold a total of 2,589,476 Karuna Therapeutics shares in the last 24 months for a total of $248,103,664.10 sold.

This page (NASDAQ:KRTX) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.